News
You’re looking at the new MG S5 EV, yet another new challenger in the increasingly busy B-segment SUV market and the fifth EV from the brand. It’ll ride on the same Modular Scalable Platform ...
Take the impressive, class-leading MG4, one of MG’s ‘new generation’ cars, and compare it with the old HS. This is a car that was well off the pace of the best family SUVs, but partly ...
This approval, granted today, marks Imfinzi as the first immunotherapy for patients in this setting. The FDA’s decision was based on the NIAGARA Phase III trial results, which demonstrated significant ...
WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has approved AstraZeneca’s IMFINZI® (durvalumab) combined with gemcitabine and cisplatin for the neoadjuvant treatment of adult patients ...
AstraZeneca's drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows ...
In general, if IMFINZI requires interruption or discontinuation, administer systemic corticosteroid therapy (1 mg to 2 mg/kg/day prednisone or equivalent) until improvement to Grade 1 or less.
Dave Fredrickson, Executive Vice President, Oncology Haematology Business Unit, AstraZeneca, said: “Today’s approval for Imfinzi represents a paradigm shift, bringing the first perioperative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results